Total Payments
$146,549
2024 Payments
$18,040
Companies
24
Transactions
326
Medicare Patients
1,086
Medicare Billing
$859,637
Payment Breakdown by Category
Other$88,597 (60.5%)
Research$23,071 (15.7%)
Consulting$18,125 (12.4%)
Travel$10,323 (7.0%)
Food & Beverage$6,433 (4.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $81,847 | 41 | 55.8% |
| Unspecified | $23,071 | 4 | 15.7% |
| Consulting Fee | $18,125 | 11 | 12.4% |
| Travel and Lodging | $10,323 | 42 | 7.0% |
| Honoraria | $6,750 | 4 | 4.6% |
| Food and Beverage | $6,433 | 224 | 4.4% |
Payments by Type
General
$123,478
322 transactions
Research
$23,071
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $48,418 | 92 | $0 (2021) |
| ABBVIE INC. | $41,206 | 93 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $25,432 | 37 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $23,109 | 7 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $5,142 | 10 | $0 (2020) |
| Merz Pharmaceuticals, LLC | $1,964 | 12 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $157.30 | 7 | $0 (2022) |
| Acorda Therapeutics, Inc | $153.12 | 10 | $0 (2022) |
| Amneal Pharmaceuticals LLC | $142.05 | 8 | $0 (2024) |
| Impax Laboratories, Inc. | $137.14 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,040 | 25 | ABBVIE INC. ($17,969) |
| 2023 | $6,242 | 34 | AbbVie Inc. ($6,098) |
| 2022 | $17,165 | 46 | ABBVIE INC. ($16,975) |
| 2021 | $18,030 | 47 | Allergan, Inc. ($12,367) |
| 2020 | $29,376 | 35 | Neurocrine Biosciences, Inc. ($23,081) |
| 2019 | $18,945 | 44 | Allergan Inc. ($10,391) |
| 2018 | $21,942 | 51 | Ipsen Biopharmaceuticals, Inc ($11,583) |
| 2017 | $16,808 | 44 | Allergan Inc. ($12,984) |
All Payment Transactions
326 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/12/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Musculoskeletal | ||||||
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/24/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROLOGY | ||||||
| 05/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Neuropsychiatry | ||||||
| 05/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/24/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROLOGY | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $357.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $32.66 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $717.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $10.85 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,600.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/19/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/12/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,600.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 4, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY TO EVALUATE THE PERSISTENCE OF EFFECT AND SAFETY OF VALBENAZINE FOR THE TREATMENT OF TARDIVE DYSKINESIA | Neurocrine Biosciences, Inc. | $23,071 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 295 | 38,471 | $799,508 | $217,983 |
| 2022 | 10 | 275 | 43,125 | $806,143 | $230,916 |
| 2021 | 9 | 268 | 39,265 | $412,312 | $209,480 |
| 2020 | 9 | 248 | 40,470 | $415,815 | $201,257 |
Total Patients
1,086
Total Services
161,331
Medicare Billing
$859,637
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 35 | 23,125 | $416,250 | $114,523 | 27.5% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 17 | 14,850 | $222,750 | $60,193 | 27.0% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 31 | 101 | $57,470 | $14,034 | 24.4% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 26 | 82 | $42,122 | $8,589 | 20.4% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 30 | 98 | $17,640 | $5,459 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 63 | $15,120 | $4,484 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 31 | $10,230 | $4,080 | 39.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 43 | 77 | $6,930 | $2,614 | 37.7% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 18 | 18 | $4,716 | $1,684 | 35.7% |
| 95912 | Nerve conduction, 11-12 studies | Facility | 2023 | 14 | 14 | $4,396 | $1,605 | 36.5% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 12 | 12 | $1,884 | $716.64 | 38.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 35 | 19,576 | $341,156 | $92,445 | 27.1% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2022 | 26 | 23,050 | $317,475 | $91,831 | 28.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 33 | 108 | $51,372 | $15,762 | 30.7% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 28 | 78 | $34,577 | $9,031 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 102 | $23,632 | $8,411 | 35.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 33 | 105 | $18,276 | $6,125 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 23 | $7,209 | $2,732 | 37.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 31 | 58 | $5,220 | $1,921 | 36.8% |
| 95912 | Nerve conduction, 11-12 studies | Facility | 2022 | 12 | 13 | $4,082 | $1,428 | 35.0% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 11 | 12 | $3,144 | $1,229 | 39.1% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2021 | 44 | 31,120 | $241,180 | $125,516 | 52.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 18 | 7,670 | $63,278 | $37,578 | 59.4% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 35 | 112 | $42,816 | $16,709 | 39.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 100 | $18,700 | $8,932 | 47.8% |
About Dr. David Riley, MD
Dr. David Riley, MD is a Neurology healthcare provider based in Beachwood, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568481976.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Riley, MD has received a total of $146,549 in payments from pharmaceutical and medical device companies, with $18,040 received in 2024. These payments were reported across 326 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($81,847).
As a Medicare-enrolled provider, Riley has provided services to 1,086 Medicare beneficiaries, totaling 161,331 services with total Medicare billing of $859,637. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Beachwood, OH
- Active Since 07/18/2006
- Last Updated 01/18/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568481976
Products in Payments
- BOTOX (Biological) $70,177
- INGREZZA (Drug) $23,100
- Dysport (Drug) $11,619
- BOTOX (Drug) $10,303
- DYSPORT (Drug) $10,264
- XEOMIN (Biological) $5,142
- Dysport 300 U-1 (Drug) $3,567
- BOTOX NEURO REHAB (Drug) $3,366
- Xeomin (Biological) $1,964
- RYTARY (Drug) $279.19
- BOTOX CHRONIC MIGRAINE (Drug) $158.86
- KYNMOBI (Drug) $157.30
- INBRIJA (Drug) $153.12
- UBRELVY (Drug) $150.69
- QULIPTA (Drug) $133.64
- NUPLAZID (Drug) $113.34
- DUOPA (Drug) $108.17
- ACTIVA (Device) $76.97
- NORTHERA (Drug) $73.53
- Xadago (Drug) $65.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Beachwood
Dr. Harold Mars, M.d, M.D
Neurology — Payments: $6,487
Neurology $6,487
Dr. Lara Feldman, D.o, D.O
Neurology — Payments: $4,200
Neurology $4,200
Dr. Matthew Eccher, Md, MD
Neurology — Payments: $73.50
Neurology $73.50
Stefan Dupont, M.d, M.D
Neurology — Payments: $28.53
Neurology $28.53
Dr. Khalid Alqadi, M.d, M.D
Neurology
Neurology
Jennifer Williams
Neurology
Neurology